Core Viewpoint - Dapu Biotech aims to create a new generation of intelligent life science solutions, focusing on the deep integration of AI and biotechnology [1] Company Overview - Dapu Biotech was founded in 2018, incubated at the Hong Kong University of Science and Technology, and is a leading enterprise in high-throughput droplet microfluidics technology in China [5] - The company has R&D and production centers in Shenzhen and Jiaxing, with a team of nearly 100 people dedicated to applying droplet microfluidics technology in biomedicine and precision medicine [5] - Dapu Biotech aims to provide a complete solution integrating the R&D and production of microfluidic chips, instruments, and reagents [5] Product Offerings - The company has commercialized multiple scientific instruments based on droplet microfluidics technology, including: - CytoSpark® Droplet Microfluidic High-throughput Screening System - OMNIdrop® System - Galaxy Single Cell Analysis System - Nebula dPCR System - Exostar Extracellular Vesicles Analysis System - These products are applicable in various fields such as antibody screening, enzyme directed evolution, strain screening, small molecule compound screening, cancer research, tumor early screening, virus quantification, and biopharmaceutical quality control [6] System Advantages - OMNIdrop® System features: - Multifunctional integration of droplet generation, fusion, reading, and sorting - Dual-drive pressure system for easy switching - High-speed droplet generation of 100 to 8000 droplets per second, with a million droplets prepared in just 10 minutes - High compatibility with commonly used biological experimental consumables [9] - CytoSpark® CSP System advantages include: - Efficient screening of complex transmembrane proteins - Unique non-activation screening technology - Breakthrough in single-experiment coverage of over one million B cells, improving efficiency by 10 to 100 times [14] Industry Events - The SynBioCon 2025 conference will be held from August 20-22 in Ningbo, Zhejiang, focusing on the integration of AI and biological manufacturing, and exploring trends in the biomanufacturing industry [18]